Topoisomerase I inhibitors in the treatment of head and neck cancer

ONCOLOGY

Volumn 15, Issue 7, 2001, Pages 47-52

  Murphy, Barbara A ^a   Cmelak, A ^b   Burkey, B ^b   Netterville, J ^b   Shyr, Y ^b   Douglas, S ^b   Smith, W ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

9 AMINO 20 CAMPTOTHECIN; 9-AMINO-20-CAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DNA TOPOISOMERASE; DRUG DERIVATIVE; ENZYME INHIBITOR; IRINOTECAN; TOPOTECAN;

DRUG ANTAGONISM; HEAD AND NECK TUMOR; HUMAN; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; HEAD AND NECK NEOPLASMS; HUMANS; SURVIVAL ANALYSIS; TOPOTECAN; TREATMENT OUTCOME;

EID: 0035404516     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Boring C, Squires T, Tong T: Cancer Statistics. CA Cancer J Clin 44(1):7-26, 1994.
2. Pecaro BC, Olson AB: Clinical and diagnostic evaluation of a patient with a tumor of the head and neck. Oral and Maxillofacial Surgery Clinics of North America 9(3):317-328, 1997.
3. Kotwall C, Sako K, Razack MS, et al: Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154(4):439-442, 1987.
4. Merino O, Lindberg R, Fletcher G: An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40(1):145-151, 1977.
5. Robertson M, Hortibrook J: The presenting symptoms of head and neck cancer. NZ Med J 95:337-341, 1982.